Urothelial Carcinoma

Urothelial carcinoma is a type of cancer that begins in the cells lining the urinary tract, called urothelial cells. These cells are found in the bladder, ureters, renal pelvis, and urethra. It is the most common type of bladder cancer, but it can also occur in other parts of the urinary system.

What is Urothelial Carcinoma?

Urothelial carcinoma is a cancer that starts in the urothelial cells, which form the inner lining of the urinary tract. This type of cancer most commonly affects the bladder, but it can also develop in other parts of the urinary system, such as the ureters, renal pelvis (part of the kidney), and urethra.

Urothelial cells are specialized cells that can stretch and contract. They line the inside of the bladder, the tubes that carry urine from the kidneys to the bladder (ureters), the part of the kidney that collects urine (renal pelvis), and the tube that carries urine out of the body (urethra). When these cells grow out of control, they can form a tumor. This condition was previously known as transitional cell carcinoma (TCC) (MedlinePlus). While urothelial carcinoma can occur anywhere along the urinary tract, it is most frequently found in the bladder (Mayo Clinic). The cancer can be non-invasive, meaning it is only in the lining, or invasive, meaning it has grown into deeper layers of the urinary tract wall. The stage and grade of the cancer help doctors determine the best treatment plan and predict the outlook (Mayo Clinic).

Symptoms

The most common symptom of urothelial carcinoma is blood in the urine (hematuria), which is often painless and may be visible or only detectable with a lab test. Other symptoms can include frequent or urgent urination, pain during urination (dysuria), and back or pelvic pain.

Blood in the urine (hematuria) is the most common sign of urothelial carcinoma and can appear as pink, red, or cola-colored urine (Mayo Clinic). Sometimes, the blood is not visible to the naked eye and is only found during a routine urine test. It's important to note that blood in the urine does not always mean cancer, but it should always be checked by a doctor (MedlinePlus). Other symptoms that may occur include needing to urinate more often than usual (frequent urination) or feeling a sudden, strong urge to urinate (urgent urination). Some people may also experience a burning sensation or pain when they urinate (dysuria). If the cancer has grown larger or spread, it might cause pain in the lower back or pelvis (Mayo Clinic). These symptoms are not unique to urothelial carcinoma and can be caused by other conditions like urinary tract infections, so a medical evaluation is essential.

Causes & risk factors

Urothelial carcinoma develops when urothelial cells undergo changes (mutations) in their DNA, leading to uncontrolled growth. While the exact cause of these mutations is often unknown, several risk factors significantly increase the chance of developing this cancer, with smoking being the most prominent.

The primary cause of urothelial carcinoma is damage to the DNA of urothelial cells, which can lead them to grow abnormally and form tumors (Mayo Clinic). While these genetic changes can happen randomly, certain exposures and lifestyle choices are strongly linked to an increased risk. Smoking is the leading risk factor for urothelial carcinoma, significantly increasing a person's risk compared to non-smokers (MedlinePlus, Mayo Clinic). Harmful chemicals in tobacco smoke are processed by the kidneys and end up in the urine, damaging the urothelial lining. Exposure to certain industrial chemicals, such as aromatic amines found in dyes, rubber, and leather manufacturing, also raises the risk (MedlinePlus). Other risk factors include chronic irritation of the bladder, such as from long-term use of urinary catheters or recurrent bladder stones (MedlinePlus). Certain medications, like the chemotherapy drug cyclophosphamide and the diabetes drug pioglitazone, have also been linked to an increased risk. Exposure to arsenic in drinking water, a personal history of bladder cancer, a family history of the disease, and being older, male, or white are also factors that can increase risk (MedlinePlus, Mayo Clinic).

How it's diagnosed

Diagnosing urothelial carcinoma typically begins with a review of your symptoms and medical history, followed by urine tests to check for blood or cancer cells. A key diagnostic procedure is cystoscopy, where a doctor uses a thin, lighted tube to examine the inside of the bladder and take tissue samples (biopsy) for further analysis.

If urothelial carcinoma is suspected, your doctor will likely start with a physical exam and ask about your symptoms. Urine tests are common first steps; a urine culture can rule out infection, and urine cytology looks for cancer cells under a microscope (MedlinePlus, Mayo Clinic). A cystoscopy is a crucial procedure for diagnosis. During this procedure, a doctor inserts a thin, flexible tube with a camera (cystoscope) through the urethra into the bladder to visualize the lining (Mayo Clinic). If any suspicious areas are found, a small tissue sample (biopsy) is taken and sent to a lab for examination by a pathologist. This helps confirm the diagnosis and determine the type and grade of the cancer (MedlinePlus). Imaging tests are also used to look for tumors and determine if the cancer has spread. These may include a CT urogram, which uses a special dye to highlight the urinary tract, or an MRI. Other imaging, such as an intravenous pyelogram (IVP) or ultrasound, may also be used to get detailed pictures of the kidneys, ureters, and bladder (MedlinePlus, Mayo Clinic). These tests help doctors stage the cancer, which is vital for planning treatment.

Treatment options

Treatment for urothelial carcinoma depends on the cancer's stage, grade, and location, as well as your overall health. Common approaches include surgery to remove the tumor, chemotherapy to kill cancer cells, radiation therapy, immunotherapy to boost the body's immune response, and targeted therapy that attacks specific cancer cell weaknesses.

The choice of treatment for urothelial carcinoma is highly individualized. For early-stage, non-invasive bladder cancer, surgery to remove the tumor through the urethra (transurethral resection of bladder tumor, or TURBT) is often the first step (Mayo Clinic). After TURBT, medication may be placed directly into the bladder (intravesical therapy), such as chemotherapy drugs or immunotherapy agents like Bacillus Calmette-Guérin (BCG), to reduce the risk of recurrence (Cochrane Library, Mayo Clinic). For more advanced or invasive cancers, more extensive surgery may be needed. This could involve removing part of the bladder (segmental cystectomy) or the entire bladder (radical cystectomy), along with nearby lymph nodes (Mayo Clinic). If the cancer is in the upper urinary tract (renal pelvis or ureter), surgery to remove the affected kidney and ureter (nephroureterectomy) may be performed (MedlinePlus). Systemic treatments, which affect the whole body, include chemotherapy, immunotherapy, and targeted therapy. Chemotherapy uses drugs to kill cancer cells throughout the body (MedlinePlus). Immunotherapy helps your body's immune system fight cancer (Mayo Clinic). Targeted therapy focuses on specific abnormalities within cancer cells to block their growth (Mayo Clinic). Radiation therapy, which uses high-energy beams to kill cancer cells, may also be used, sometimes in combination with other treatments (MedlinePlus). Your doctor will discuss the most appropriate treatment plan for your specific situation.

Recovery & outlook

The recovery and outlook for urothelial carcinoma vary greatly depending on factors like the cancer's stage, grade, location, and how well it responds to treatment. Early detection and treatment often lead to a better prognosis. Regular follow-up care is crucial, as recurrence is common, especially for non-invasive forms of the disease.

Recovery from urothelial carcinoma treatment can involve a period of healing, especially after surgery. For example, after a radical cystectomy, patients will need to learn how to manage urine diversion, which is a new way for urine to leave the body (Mayo Clinic). This might involve an external bag or an internal pouch. Physical recovery, managing side effects of chemotherapy or radiation, and emotional support are all important aspects of the recovery process. The outlook (prognosis) for urothelial carcinoma depends heavily on whether the cancer is non-invasive or invasive, and if it has spread to other parts of the body (MedlinePlus). Cancers caught at an early, non-invasive stage generally have a better prognosis. However, even non-invasive urothelial carcinoma has a high chance of returning (recurrence), which is why ongoing surveillance and follow-up appointments are essential (Mayo Clinic). Regular follow-up care typically includes frequent cystoscopies and imaging tests to monitor for any signs of recurrence or new tumors (Mayo Clinic). Adopting a healthy lifestyle, including quitting smoking, can also improve long-term outcomes and reduce the risk of recurrence. Your care team will provide a personalized follow-up schedule and support to help you manage your health after treatment.

When to see a doctor

You should see a doctor promptly if you notice any blood in your urine, even if it's a small amount or appears only once. Other concerning symptoms that warrant a medical evaluation include persistent changes in urination patterns, such as frequent or urgent urination, or pain during urination, especially if these symptoms are new or worsening.

It is crucial to contact your doctor right away if you observe any blood in your urine (hematuria), whether it's visible as pink, red, or cola-colored, or if a urine test shows microscopic blood (MedlinePlus). Even if the blood appears only once and then goes away, it needs to be investigated, as painless hematuria is a common early sign of urothelial carcinoma (Mayo Clinic). You should also seek medical advice if you experience persistent or worsening urinary symptoms. These include needing to urinate much more often than usual (frequent urination), feeling a strong, sudden need to urinate (urgent urination), or experiencing pain or burning during urination (dysuria) (Mayo Clinic). While these symptoms can be caused by less serious conditions like urinary tract infections, it's important to rule out cancer. Additionally, if you have unexplained back pain or pelvic pain, especially if you have risk factors for urothelial carcinoma, you should discuss these symptoms with your healthcare provider (MedlinePlus). Early detection significantly improves treatment outcomes, so do not delay seeking medical attention for any concerning urinary or pain symptoms.

Frequently asked questions

Is urothelial carcinoma always cancer of the bladder?

No, while urothelial carcinoma most commonly affects the bladder, it can also develop in other parts of the urinary tract. This includes the ureters (tubes connecting kidneys to bladder), the renal pelvis (part of the kidney), and the urethra (MedlinePlus).

What is the main cause of urothelial carcinoma?

The leading cause of urothelial carcinoma is smoking. Chemicals in tobacco smoke are filtered by the kidneys and can damage the urothelial cells lining the urinary tract, significantly increasing the risk of developing this cancer (Mayo Clinic, MedlinePlus).

Can urothelial carcinoma be cured?

The possibility of a cure depends on many factors, including the cancer's stage, grade, and how it responds to treatment. Early-stage, non-invasive urothelial carcinoma often has a good prognosis with treatment, but recurrence is common. More advanced cancers are harder to cure but can often be managed (MedlinePlus, Mayo Clinic).

What is the difference between non-invasive and invasive urothelial carcinoma?

Non-invasive urothelial carcinoma means the cancer cells are only in the inner lining of the urinary tract and have not grown into deeper layers. Invasive urothelial carcinoma means the cancer has spread into the muscle layer or beyond, making it more serious and potentially harder to treat (Mayo Clinic).

What is intravesical therapy?

Intravesical therapy is a treatment where medication, such as chemotherapy drugs or immunotherapy agents like BCG, is delivered directly into the bladder through a catheter. This approach is often used for non-muscle invasive bladder cancer to kill cancer cells and reduce the risk of recurrence (Mayo Clinic, Cochrane Library).

How often do I need follow-up appointments after treatment?

After treatment for urothelial carcinoma, regular follow-up appointments are crucial because the cancer has a high chance of returning, especially for non-invasive types. The frequency of these appointments, which often include cystoscopies and imaging, will be determined by your doctor based on your specific cancer and risk of recurrence (Mayo Clinic).

Sources

• MedlinePlus — Urothelial Carcinoma
• Mayo Clinic — Urothelial Carcinoma
• Cochrane Library — Urothelial Carcinoma